Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Computed Tomography | Research article

Factors contributing to diagnostic delay of Caroli syndrome: a single-center, retrospective study

Authors: Wen Shi, Xiao-ming Huang, Yun-lu Feng, Feng-dan Wang, Xiao-xing Gao, Yang Jiao

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Caroli syndrome (CS) is a rare congenital disorder without pathognomonic clinical symptoms or laboratory findings; therefore, the diagnosis is often delayed. The objective of this study was to investigate the diagnostic delay and associated risk factors in CS patients.

Methods

This was a retrospective analysis of 16 CS patients admitted to a single tertiary medical center on mainland China. The diagnostic timelines of CS patients were reviewed to demonstrate the initial findings of CS at diagnosis, the risk factors associated with diagnostic delay, and potential clues leading to early diagnosis.

Results

The median diagnostic delay was 1.75 years (range: 1 month to 29 years, interquartile range: 6.2 years) in 16 enrolled CS patients. Sex, age, and initial symptoms were not associated with diagnostic delay. 87.5% of CS patients were diagnosed by imaging, and the accuracies of ultrasonography, computed tomography (CT), and magnetic resonance cholangiopancreatography were 25, 69.2, and 83.3%, respectively. The median diagnostic delays for patients with or without CT performed at the first hospital visited according to physician and radiologist suspicion of the diagnosis were 7.4 months and 6 years, respectively (p = 0.021). Hepatic cysts with splenomegaly were detected by ultrasound in over half of CS patients.

Conclusions

The majority of CS patients were not diagnosed until complications of portal hypertension had already developed. Recognition and early suspicion of the disease were important factors influencing diagnostic delay of CS. Hepatic cysts plus splenomegaly detected by US might raise the clinical suspicion to include CS in the differential diagnosis.
Literature
1.
go back to reference Yonem O, Bayraktar Y. Clinical characteristics of Caroli's syndrome. World J Gastroenterol. 2007;13(13):1934–7.CrossRef Yonem O, Bayraktar Y. Clinical characteristics of Caroli's syndrome. World J Gastroenterol. 2007;13(13):1934–7.CrossRef
2.
go back to reference Bakoyiannis A, Delis S, Triantopoulou C, Dervenis C. Rare cystic liver lesions: a diagnostic and managing challenge. World J Gastroenterol. 2013;19(43):7603–19.CrossRef Bakoyiannis A, Delis S, Triantopoulou C, Dervenis C. Rare cystic liver lesions: a diagnostic and managing challenge. World J Gastroenterol. 2013;19(43):7603–19.CrossRef
3.
go back to reference Shorbagi A, Bayraktar Y. Experience of a single center with congenital hepatic fibrosis: a review of the literature. World J Gastroenterol. 2010;16(6):683–90.CrossRef Shorbagi A, Bayraktar Y. Experience of a single center with congenital hepatic fibrosis: a review of the literature. World J Gastroenterol. 2010;16(6):683–90.CrossRef
4.
go back to reference Wang ZX, Li YG, Wang RL, Li YW, Li ZY, Wang LF, Yang HY, Zhu Y, Wang Y, Bai YF, et al. Clinical classification of Caroli’s disease: an analysis of 30 patients. HPB (Oxford). 2015;17(3):278–83.CrossRef Wang ZX, Li YG, Wang RL, Li YW, Li ZY, Wang LF, Yang HY, Zhu Y, Wang Y, Bai YF, et al. Clinical classification of Caroli’s disease: an analysis of 30 patients. HPB (Oxford). 2015;17(3):278–83.CrossRef
5.
go back to reference Zhang DY, Ji ZF, Shen XZ, Liu HY, Pan BJ, Dong L. Caroli’s disease: a report of 14 patients and review of the literature. J Dig Dis. 2012;13(9):491–5.CrossRef Zhang DY, Ji ZF, Shen XZ, Liu HY, Pan BJ, Dong L. Caroli’s disease: a report of 14 patients and review of the literature. J Dig Dis. 2012;13(9):491–5.CrossRef
6.
go back to reference Park E, Lee JM, Ahn YH, Kang HG, Ha II, Lee JH, Park YS, Kim NK, Park WY, Cheong HI. Hepatorenal fibrocystic diseases in children. Pediatr Nephrol. 2016;31(1):113–9.CrossRef Park E, Lee JM, Ahn YH, Kang HG, Ha II, Lee JH, Park YS, Kim NK, Park WY, Cheong HI. Hepatorenal fibrocystic diseases in children. Pediatr Nephrol. 2016;31(1):113–9.CrossRef
7.
go back to reference Cannella R, Giambelluca D, Diamarco M, Caruana G, Cutaia G, Midiri M, Salvaggio G. Congenital cystic lesions of the bile ducts: Imaging-Based Diagnosis. Curr Probl Diagn Radiol. 2020;49(4):285-93. Cannella R, Giambelluca D, Diamarco M, Caruana G, Cutaia G, Midiri M, Salvaggio G. Congenital cystic lesions of the bile ducts: Imaging-Based Diagnosis. Curr Probl Diagn Radiol. 2020;49(4):285-93.
8.
go back to reference Lendoire JC, Raffin G, Grondona J, Bracco R, Russi R, Ardiles V, Gondolesi G, Defelitto J, de Santibanes E, Imventarza O. Caroli’s disease: report of surgical options and long-term outcome of patients treated in Argentina. Multicenter study. J Gastrointest Surg. 2011;15(10):1814–9.CrossRef Lendoire JC, Raffin G, Grondona J, Bracco R, Russi R, Ardiles V, Gondolesi G, Defelitto J, de Santibanes E, Imventarza O. Caroli’s disease: report of surgical options and long-term outcome of patients treated in Argentina. Multicenter study. J Gastrointest Surg. 2011;15(10):1814–9.CrossRef
9.
go back to reference Bettini G, Mandrioli L, Morini M. Bile duct dysplasia and congenital hepatic fibrosis associated with polycystic kidney (Caroli syndrome) in a rat. Vet Pathol. 2003;40(6):693–4.CrossRef Bettini G, Mandrioli L, Morini M. Bile duct dysplasia and congenital hepatic fibrosis associated with polycystic kidney (Caroli syndrome) in a rat. Vet Pathol. 2003;40(6):693–4.CrossRef
10.
go back to reference Schiano TD, Fiel MI, Miller CM, Bodenheimer HC Jr, Min AD. Adult presentation of Caroli’s syndrome treated with orthotopic liver transplantation. Am J Gastroenterol. 1997;92(10):1938–40.PubMed Schiano TD, Fiel MI, Miller CM, Bodenheimer HC Jr, Min AD. Adult presentation of Caroli’s syndrome treated with orthotopic liver transplantation. Am J Gastroenterol. 1997;92(10):1938–40.PubMed
11.
go back to reference Keane F, Hadzic N, Wilkinson ML, Qureshi S, Reid C, Baker AJ, Mieli-Vergani G. Neonatal presentation of Caroli’s disease. Arch Dis Child Fetal Neonatal Ed. 1997;77(2):F145–6.CrossRef Keane F, Hadzic N, Wilkinson ML, Qureshi S, Reid C, Baker AJ, Mieli-Vergani G. Neonatal presentation of Caroli’s disease. Arch Dis Child Fetal Neonatal Ed. 1997;77(2):F145–6.CrossRef
12.
go back to reference Zhang WC, Zhao FR, Chen J, Chen WX. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One. 2014;9(3):e92267.CrossRef Zhang WC, Zhao FR, Chen J, Chen WX. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One. 2014;9(3):e92267.CrossRef
13.
go back to reference Kassahun WT, Kahn T, Wittekind C, Mossner J, Caca K, Hauss J, Lamesch P. Caroli's disease: liver resection and liver transplantation. Experience in 33 patients. Surgery. 2005;138(5):888–98.CrossRef Kassahun WT, Kahn T, Wittekind C, Mossner J, Caca K, Hauss J, Lamesch P. Caroli's disease: liver resection and liver transplantation. Experience in 33 patients. Surgery. 2005;138(5):888–98.CrossRef
14.
go back to reference Hwang MJ, Kim TN. Diffuse-type Caroli disease with characteristic central dot sign complicated by multiple intrahepatic and common bile duct stones. Clin Endosc. 2017;50(4):400–3.CrossRef Hwang MJ, Kim TN. Diffuse-type Caroli disease with characteristic central dot sign complicated by multiple intrahepatic and common bile duct stones. Clin Endosc. 2017;50(4):400–3.CrossRef
15.
go back to reference Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21(9):1023–32 quiz 1033-1024.CrossRef Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21(9):1023–32 quiz 1033-1024.CrossRef
16.
go back to reference Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, et al. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol. 2015;13(1):155–164.e156.CrossRef Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, et al. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol. 2015;13(1):155–164.e156.CrossRef
17.
go back to reference Yokomichi H, Tsuji K, Hayashi Y, Kaneko M, Nakadoi K, Ishida Y, Kuwabara T, Tsumuna T, Sumida T, Nagata S, et al. A case of multiple hepatic peribiliary cysts which contributed to the obstructive jaundice and led to liver failure at the young man with von Recklinghausen’s disease. Hepatol Res. 2006;35(3):222–7.PubMed Yokomichi H, Tsuji K, Hayashi Y, Kaneko M, Nakadoi K, Ishida Y, Kuwabara T, Tsumuna T, Sumida T, Nagata S, et al. A case of multiple hepatic peribiliary cysts which contributed to the obstructive jaundice and led to liver failure at the young man with von Recklinghausen’s disease. Hepatol Res. 2006;35(3):222–7.PubMed
18.
go back to reference Das A, Arya SV, Soni N, Gowda GG, Kalwaniya DS. A rare presentation of hepatic and splenic cystic malignant fibrous histiocytoma: a case report and literature review. Int J Surg Case Rep. 2013;4(1):139–41.CrossRef Das A, Arya SV, Soni N, Gowda GG, Kalwaniya DS. A rare presentation of hepatic and splenic cystic malignant fibrous histiocytoma: a case report and literature review. Int J Surg Case Rep. 2013;4(1):139–41.CrossRef
Metadata
Title
Factors contributing to diagnostic delay of Caroli syndrome: a single-center, retrospective study
Authors
Wen Shi
Xiao-ming Huang
Yun-lu Feng
Feng-dan Wang
Xiao-xing Gao
Yang Jiao
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01442-5

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.